LUIS GONZAGA
PAZ-ARES RODRÍGUEZ
Profesor titular de universidad
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (5)
2023
-
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer
Nature Communications, Vol. 14, Núm. 1
2020
-
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium
British Journal of Cancer, Vol. 123, Núm. 5, pp. 793-802
2018
-
MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma
Journal of Experimental and Clinical Cancer Research, Vol. 37, Núm. 1
-
MyD88 and TLR4 Expression in Epithelial Ovarian Cancer
Mayo Clinic Proceedings, Vol. 93, Núm. 3, pp. 307-320
2017
-
Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer
Oncotarget, Vol. 8, Núm. 62, pp. 105196-105210